← back to search

Paul A. Townsend

Manchester Academic Health Science Centre · GB
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Heat shock proteins research, Adipose Tissue and Metabolism, Prostate Cancer Treatment and Research, and Advanced Proteomics Techniques and Applications.
h-index
56
citations
10,923
works
301
NIH funding
primary concept
email

Recent publications

Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
Nature Cancer 2026cited by 1position: middledoi
Automated Liquid Handling Extraction and Rapid Quantification of Underivatized Amino Acids and Tryptophan Metabolites from Human Serum and Plasma Using Dual-Column U(H)PLC-MRM-MS and Its Application to Prostate Cancer Study
Metabolites 2024cited by 8position: middledoi
Automated liquid handling extraction and rapid quantification of underivatized amino acids and tryptophan metabolites from human serum and plasma using dual-column U(H)PLC-MRM-MS and its application to prostate cancer study
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 2position: middledoi
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry
The American Journal of Human Genetics 2023cited by 23position: middledoi
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study
British Journal of Cancer 2023cited by 8position: middledoi
Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry
medRxiv 2023cited by 2position: middledoi
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score
Prostate Cancer and Prostatic Diseases 2022cited by 38position: middledoi
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
Nature Communications 2021cited by 76position: middledoi
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
Prostate Cancer and Prostatic Diseases 2021cited by 25position: middledoi
Prostate cancer risk stratification improved across multiple ancestries with new polygenic hazard score
medRxiv 2021cited by 2position: middledoi
An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk
Nature Communications 2020cited by 245position: middledoi
Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan
Nature Communications 2020cited by 76position: middledoi
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
Cancers 2020cited by 24position: middledoi
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer
medRxiv 2020cited by 1position: middledoi
A Deep Learning Framework for Predicting Response to Therapy in Cancer
Cell Reports 2019cited by 212position: middledoi
Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining
Pharmacology & Therapeutics 2019cited by 124position: middledoi
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
medRxiv 2019cited by 13position: middledoi
Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma
Nature Communications 2019cited by 6position: middledoi
Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
Nature Communications 2019cited by 1position: middledoi
Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
Nature Communications 2019cited by 1position: middledoi
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
Nature Communications 2019cited by 0position: middledoi
Large-scale transcriptome-wide association study identifies new prostate cancer risk regions
Nature Communications 2018cited by 175position: middledoi
Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia
Nature Communications 2018cited by 85position: middledoi
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
Nature Communications 2018cited by 59position: middledoi
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
Cancer Epidemiology Biomarkers & Prevention 2018cited by 38position: middledoi
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study
Breast Cancer Research 2018cited by 18position: middledoi
Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility
Nature Communications 2017cited by 51position: middledoi
Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing
Nature Cell Biology 2016cited by 308position: middledoi
Robust, universal biomarker assay to detect senescent cells in biological specimens
Aging Cell 2016cited by 249position: middledoi
MKK7 and ARF
Cell Cycle 2014cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiří Bártek · Karolinska University Hospital4 papers (2014–2019)Vassilis G. Gorgoulis · RGenix (United States)4 papers (2014–2019)Athanassios Kotsinas · Indiana University School of Medicine4 papers (2014–2019)Sonali Narang · New York University2 papers (2019–2019) · 2 papers (2024–2024)Iannis Aifantis · NYU Langone Health2 papers (2019–2019)Konstantinos Vougas · National and Kapodistrian University of Athens2 papers (2019–2019) · 2 papers (2024–2024) · 2 papers (2024–2024) · 2 papers (2024–2024)Theodore Sakellaropoulos · New York University2 papers (2019–2019)Lee A. Gethings · University of Manchester2 papers (2024–2024)Petros P. Sfikakis · Harbor–UCLA Medical Center2 papers (2019–2019)Alexander Polyzos · Cornell University2 papers (2019–2019)Filippos Koinis · National and Kapodistrian University of Athens2 papers (2019–2019)Christiane A. Opitz · Institute for Transfusion Medicine2 papers (2024–2024) · 2 papers (2024–2024) · 2 papers (2019–2019)Russell Petty · University of Dundee2 papers (2019–2019)Kathrin Thedieck · German Cancer Research Center2 papers (2024–2024)